Abbreviated R-CHOP in Completely Excised Stage I or II DLBCL
Status:
Unknown status
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This study aims; to assess the efficacy of shortened systemic chemotherapy in patients with
completely excised CD20 positive Diffuse Large B-cell Lymphoma (DLBCL) with Ann Arbor Stage I
or II.